Trials / Sponsors / Elixiron Immunotherapeutics (Hong Kong) Ltd.
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients Non-segmental Vitiligo | Phase 2 | 2025-12-30 |
| Recruiting | A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Mild, Moderate, or Severe Alzheimer's Disease | Phase 2 | 2024-12-16 |
| Completed | First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers Healthy | Phase 1 | 2021-10-01 |
| Completed | A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers Healthy Volunteers | Phase 1 | 2019-12-27 |